Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Oct 27, 2026; 18(10): 124385
Published online Oct 27, 2026. doi: 10.4240/wjgs.124385
Published online Oct 27, 2026. doi: 10.4240/wjgs.124385
Figure 3 Final RoB 2 judgments for the disease-free survival/recurrence-free survival outcome after author review.
D1: Randomization process; D2: Deviations from intended interventions; D3: Missing outcome data; D4: Outcome measurement; D5: Selection of the reported result. The corresponding signalling-question rationale and source-access notes are provided in the audit workbook. The trial reported by Xie et al[20] was eligible qualitatively but did not contribute a hazard ratio to the quantitative synthesis. ARTIST: Adjuvant Chemoradiotherapy in Stomach Tumors.
- Citation: Lu HH, Xie JH, Li XR. Adjuvant chemoradiotherapy vs chemotherapy after R0 D2 gastrectomy for gastric cancer: Meta-analysis of randomized trials. World J Gastrointest Surg 2026; 18(10): 124385
- URL: https://www.wjgnet.com/1948-9366/full/v18/i10/124385.htm
- DOI: https://dx.doi.org/10.4240/wjgs.124385